Yuko Palesch to United States
This is a "connection" page, showing publications Yuko Palesch has written about United States.
Connection Strength
0.280
-
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011 Dec; 15(3):559-76.
Score: 0.041
-
A web-based medical safety reporting system for a large multicenter clinical trial: the ALIAS experience. Contemp Clin Trials. 2010 Nov; 31(6):536-43.
Score: 0.038
-
Regional Differences in the Response to Acute Blood Pressure Lowering After Cerebral Hemorrhage. Neurology. 2021 02 02; 96(5):e740-e751.
Score: 0.019
-
National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke. Stroke. 2020 01; 51(1):282-290.
Score: 0.018
-
Association between cigarette and alcohol consumption and Raynaud's phenomenon. J Clin Epidemiol. 1999 Apr; 52(4):321-8.
Score: 0.017
-
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. Int J Stroke. 2019 02; 14(2):207-214.
Score: 0.017
-
Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III. Prehosp Emerg Care. 2017 Sep-Oct; 21(5):539-544.
Score: 0.015
-
Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc. 2017 May 08; 6(5).
Score: 0.015
-
Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet. Stroke. 2017 03; 48(3):813-819.
Score: 0.015
-
The National Institutes of Health StrokeNet: A User's Guide. Stroke. 2016 Feb; 47(2):301-3.
Score: 0.014
-
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Feb; 47(2):581-641.
Score: 0.014
-
Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014 Jun; 45(6):1791-8.
Score: 0.012
-
Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial. Int J Stroke. 2014 Feb; 9(2):226-31.
Score: 0.012
-
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke. 2010 Nov; 41(11):2581-6.
Score: 0.009
-
Design of the economic evaluation for the Interventional Management of Stroke (III) trial. Int J Stroke. 2008 May; 3(2):138-44.
Score: 0.008
-
Analysis of clustered matched-pair data. Stat Med. 2003 Aug 15; 22(15):2417-28.
Score: 0.006
-
The nursing home population: different perspectives and implications for policy. Health Care Financ Rev. 1981 Dec; 3(2):15-23.
Score: 0.005
-
The body mass index-mortality relationship in white and African American women. Obes Res. 1998 Jul; 6(4):268-77.
Score: 0.004
-
Sex differences in declining cohort death rates from heart disease. Am J Public Health. 1982 Feb; 72(2):161-6.
Score: 0.001